EUVIMEDEUVIMED entdecken
Open Access

Fragment Screening to Identify Inhibitors Targeting Ribosome Binding of Shiga Toxin 2

Michael J Rudolph, Anastasiia M Tsymbal, Arkajyoti Dutta, Simon A Davis, Benjamin Algava, Jacques Y Roberge iD, Nilgun E Tumer iD, Xiao-Ping Li iD

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Michael J Rudolph und 7 weiteren Autor:innen. Beteiligte Einrichtung: New York Structural Biology Center, 89 Convent Ave, New York, New York 10027, United States. Hauptthemen laut MEDLINE: Ribosomes, Shiga Toxin 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shiga toxins are the main virulence factors of Shiga toxin producing E. coli (STEC) and S. dysenteriae. There is no effective therapy to counter the disease caused by these toxins. The A1 subunits of Shiga toxins bind the C-termini of ribosomal P-stalk proteins to depurinate the sarcin/ricin loop. The ribosome binding site of Shiga toxin 2 has not been targeted by small molecules. We screened a fragment library against the A1 subunit of Shiga toxin 2 (Stx2A1) and identified a fragment, BTB13086, which bound at the ribosome binding site and mimicked the binding mode of the P-stalk proteins. We synthesized analogs of BTB13086 and identified a series of molecules with similar affinity and inhibitory activity. These are the first compounds that bind at the ribosome binding site of Stx2A1 and inhibit activity. These compounds hold great promise for further inhibitor development against STEC infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RibosomesShiga Toxin 2Binding SitesProtein BindingShiga-Toxigenic Escherichia coliHumans

Stichwörter der Autor:innen

Shiga toxinsX-ray crystal structuredepurination inhibitionfragment-based drug discoveryribosome bindingribosome-inactivating protein

Substanzen

Shiga Toxin 2

Autor:innen und Institutionen

  • New York Structural Biology Center, 89 Convent Ave, New York, New York 10027, United States.
  • Molecular Design and Synthesis Core, Rutgers University Biomolecular Innovations Cores, Office for Research, Rutgers University, 610 Taylor Rd, Piscataway, New Jersey 08854, United States.
  • Department of Plant Biology, Rutgers, The State University of New Jersey, 59 Dudley Road, New Brunswick, New Jersey 08901, United States.

ORCID-Profile: Jacques Y Roberge, Nilgun E Tumer, Xiao-Ping Li

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Rudolph, M. J., Tsymbal, A. M., Dutta, A., Davis, S. A., Algava, B., Roberge, J. Y., Tumer, N. E., & Li, X. P. (2024). Fragment Screening to Identify Inhibitors Targeting Ribosome Binding of Shiga Toxin 2. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00224

Vancouver

Rudolph MJ, Tsymbal AM, Dutta A, Davis SA, Algava B, Roberge JY, et al. Fragment Screening to Identify Inhibitors Targeting Ribosome Binding of Shiga Toxin 2. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00224

BibTeX
@article{Rudolph2024,
  author = {Rudolph, Michael J and Tsymbal, Anastasiia M and Dutta, Arkajyoti and Davis, Simon A and Algava, Benjamin and Roberge, Jacques Y and Tumer, Nilgun E and Li, Xiao-Ping},
  title = {Fragment Screening to Identify Inhibitors Targeting Ribosome Binding of Shiga Toxin 2},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00224}
}
Kostenlos starten →